They concluded that GCSF is not associated with an increased risk of brain metastases in Japanese patients with de novo stage IV breast cancer, but GCSF is associated with an increased risk of distant organ metastases in Chinese patients with non-small cell lung cancer [24,25]. The gene discussed is CSF3; the disease is non-small cell lung carcinoma.